Gargi Bio Tek Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 2.56 Cr
as on 04-07-2024
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 11.63 Cr
as on 04-07-2024
- Satisfied Charges ₹ 2.93 Cr
as on 04-07-2024
About Gargi Bio Tek
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.56 Cr.
The company currently has active open charges totaling ₹11.63 Cr. The company has closed loans amounting to ₹2.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shivraj Bhosale and Sujata Bhosale serve as directors at the Company.
- CIN/LLPIN
U01122PN2005PTC020585
- Company No.
020585
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2005
- Date of AGM
26 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gargi Bio Tek?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shivraj Bhosale  | Additional Director | 13-Nov-2014 | Current |
| Sujata Bhosale | Additional Director | 13-Nov-2014 | Current |
Financial Performance and Corporate Structure Insights of Gargi Bio Tek.
Enhance accessibility to Gargi Bio Tek's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Gargi Bio Tek?
Unlock access to Gargi Bio Tek's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Hi Cell Crop Sciences Private LimitedActive 7 years 2 monthsShivraj Bhosale and Sujata Bhosale are mutual person
Tulip Greenhouses Private LimitedActive 19 years 7 monthsShivraj Bhosale and Sujata Bhosale are mutual person
- Oleum Plantations Private LimitedActive 1 year 1 month
Shivraj Bhosale and Sujata Bhosale are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 27 Mar 2008 | ₹11.63 Cr | Open |
State Bank Of India Creation Date: 10 Aug 2006 | ₹2.93 Cr | Satisfied |
How Many Employees Work at Gargi Bio Tek?
Unlock and access historical data on people associated with Gargi Bio Tek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gargi Bio Tek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gargi Bio Tek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
